Moolec Science SA(US:MLEC)2023-12-14 16:55Financial Data and Key Metrics Changes - Revenues increased to $1.7 million in Q1 2024 from $0.9 million in the previous quarter, representing a growth of 92% quarter-over-quarter, primarily driven by a full quarter consolidation of the acquired business and higher average pricing and volumes [16][39] - Operational cash utilization for the quarter was approximately $1.8 million, consistent with historical cash expense management while supporting R&D progress [39] - Gross margin increased due to stable soy origination and favorable market conditions, with admin expenses significantly lower at approximately $1.9 million compared to $3 million in the previous quarter [99] Business Line Data and Key Metrics Changes - The company successfully harvested 35 hectares of gamma-linolenic acid safflower oil (GLASO) with a yield of 1.8 tons per hectare, exceeding average yields by approximately 50% [7][8] - The expression levels of myoglobin in T3 transgenic events reached 20.4% total soluble protein, demonstrating stable expression across generations [12][35] Market Data and Key Metrics Changes - The agro-market is projected to reach $829 billion by 2025, with a focus on processed meat products such as burgers and sausages, which represents a significant opportunity for the company [28] - The company is addressing iron supplementation as an additional market opportunity, expanding its addressable market [28] Company Strategy and Development Direction - The company aims to bypass dependence on animals by genetically engineering plants to produce animal proteins, contributing to a more sustainable food industry [5][27] - Plans to scale up operations include planting between 100 to 350 hectares in fiscal year 2024, focusing on commercialization and risk reduction [31][8] - The establishment of Moo Labs, a fully owned molecular biology lab, is expected to enhance control over intellectual property and reduce costs associated with third-party labs [13][91] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the progress made in R&D and the execution of strategies, highlighting the importance of maintaining controlled cash flow while advancing the R&D pipeline [39][90] - The impact of recent economic reforms in Argentina is still uncertain, but the company has limited exposure to the region [49] Other Important Information - The company has closed a capital raise with strategic investors, resulting in $10 million of cash contributions and $21 million in-kind contributions, strengthening its liquidity position [39] - The transition from greenhouse to field trials is crucial for achieving commodity pricing for soybeans, emphasizing the need for real agronomic conditions [58][59] Q&A Session Summary Question: What are the advantages of setting up Moo Labs at Texas A&M? - The establishment of Moo Labs allows for better control over intellectual property, cost savings, and access to skilled scientists, enhancing the efficiency of R&D efforts [19][41] Question: Thoughts on accelerating commercial development for GLASO? - Management is optimistic about GLASO yields and is focused on maintaining control over the seed process while exploring potential royalty models for commercialization [22][44] Question: How will the recent economic reforms in Argentina impact the business? - The impact is still unclear, but the company has limited exposure to Argentina, and the devaluation of the peso may lower dollar-denominated expenses [49] Question: How many third-party labs are still in use? - The company continues to utilize third-party labs for specific projects while focusing on internal capabilities to maintain control over intellectual property [53][56] Question: What is the significance of moving from greenhouses to field trials? - Transitioning to field trials is essential for achieving competitive pricing and validating plant performance under real conditions [58][59]